Document Detail

Serum d-dimer as a prognostic marker in patients undergoing radiofrequency ablation of colorectal liver metastasis.
MedLine Citation:
PMID:  23020269     Owner:  NLM     Status:  In-Data-Review    
ABSTRACT Background: Although traditionally used for coagulation disorders, there has been a recent interest in serum D-dimer as a tumor marker. The aim of this prospective study is to determine its value as a tumor marker in patients with colorectal liver metastasis. Patients and Methods: Between January 2000 and October 2007, 242 patients undergoing laparoscopic radiofrequency ablation (RFA) of colorectal liver metastasis were evaluated prospectively. The relationship of D-dimer levels to pre-ablation parameters, recurrence, and survival was prospectively assessed. All data are expressed as mean ± SEM. Results: Preoperative D-dimer levels correlated with liver tumor volume (p = .04) and CEA (p = .003). D-dimer levels increased by a mean of 11.4 ± 1.5 folds after RFA on POD#7 and returned to preoperative values in three months. The rate of the elevation of D-dimer values after RFA was related to tumor volume ablated. The median overall survival was six months for patients with preoperative D-dimer > 1,000 ng/ml vs. 32 months for patients with D-dimer < 1,000 ng/ml (p = .02). On multivariate analysis preoperative serum D-dimer was an independent predictor of overall survival along with CEA and liver tumor burden. Conclusion: Serum D-dimer levels reflect liver tumor burden and independently predict survival in patients with colorectal liver metastasis undergoing RFA.
Gurkan Tellioglu; Orhan Agcaoglu; Allan Siperstein; Eren Berber
Related Documents :
10504059 - Detection of tyrosinase mrna by rt-pcr in the peripheral blood of patients with advance...
2064939 - Malignant melanoma occurring in those aged under 30 in the west of scotland 1979-1986: ...
9440169 - Long-term follow-up after uveal melanoma charged particle therapy.
11384789 - Cause-specific mortality coding. methods in the collaborative ocular melanoma study com...
6379119 - Clinical trials with staphylococcal protein a.
12407149 - Population-based assessment of clinical characteristics predicting outcome of conjuncti...
15638859 - High-dose idarubicin and busulphan as conditioning to autologous stem cell transplantat...
10504059 - Detection of tyrosinase mrna by rt-pcr in the peripheral blood of patients with advance...
8026929 - Factors contributing to the outcome in 100 adult patients with idiopathic membranous gl...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of investigative surgery : the official journal of the Academy of Surgical Research     Volume:  25     ISSN:  1521-0553     ISO Abbreviation:  J Invest Surg     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8809255     Medline TA:  J Invest Surg     Country:  England    
Other Details:
Languages:  eng     Pagination:  295-300     Citation Subset:  IM    
Endocrinology and Metabolism Institute, Division of Endocrine Surgery , Cleveland Clinic, Cleveland, OH , USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Leonardo da Vinci's Foot: Historical Evidence of Concept.
Next Document:  Effects of caffeic Acid phenethyl ester on anastomotic healing in secondary peritonitis.